1,017 filings
Page 30 of 51
8-K
ABIO
ARCA biopharma Inc
17 Aug 12
Departure of Directors or Certain Officers
12:00am
10-Q
2012 Q2
ABIO
ARCA biopharma Inc
Quarterly report
13 Aug 12
12:00am
424B5
ABIO
ARCA biopharma Inc
3 Aug 12
Prospectus supplement for primary offering
12:00am
8-K
ABIO
ARCA biopharma Inc
3 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
ABIO
ARCA biopharma Inc
30 May 12
Submission of Matters to a Vote of Security Holders
12:00am
10-Q
2012 Q1
ABIO
ARCA biopharma Inc
Quarterly report
14 May 12
12:00am
8-K
ABIO
ARCA biopharma Inc
16 Apr 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
DEF 14A
ABIO
ARCA biopharma Inc
Definitive proxy
5 Apr 12
12:00am
DEFA14A
ABIO
ARCA biopharma Inc
5 Apr 12
Additional proxy soliciting materials
12:00am
8-K
ABIO
ARCA biopharma Inc
30 Mar 12
Departure of Directors or Certain Officers
12:00am
10-K
2011 FY
ABIO
ARCA biopharma Inc
Annual report
27 Mar 12
12:00am
8-K
ABIO
ARCA biopharma Inc
26 Mar 12
Gencarotm’s Norepinephrine Lowering Likely Contributes to Its Effect In Atrial Fibrillation Prevention
12:00am
EFFECT
ABIO
ARCA biopharma Inc
26 Jan 12
Notice of effectiveness
12:00am
S-3/A
ABIO
ARCA biopharma Inc
Shelf registration (amended)
24 Jan 12
12:00am
CORRESP
ABIO
ARCA biopharma Inc
24 Jan 12
Correspondence with SEC
12:00am
CORRESP
ABIO
ARCA biopharma Inc
24 Jan 12
Correspondence with SEC
12:00am
UPLOAD
ABIO
ARCA biopharma Inc
19 Jan 12
Letter from SEC
12:00am
8-K
ABIO
ARCA biopharma Inc
19 Jan 12
Arca Biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient
12:00am
S-3
ABIO
ARCA biopharma Inc
Shelf registration
12 Jan 12
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
10 Jan 12
Confidential treatment order
12:00am